123 related articles for article (PubMed ID: 29615248)
1. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
Kim DH; Lee SH; Kim J; Lee J; Jeong JH; Kim JY; Song SU; Lee H; Cho AY; Hyeon JY; Youk S; Song CS
Vaccine; 2024 Jul; 42(18):3756-3767. PubMed ID: 38724417
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
Santos JJS; Obadan AO; Garcia SC; Carnaccini S; Kapczynski DR; Pantin-Jackwood M; Suarez DL; Perez DR
Vaccine; 2017 Oct; 35(42):5637-5643. PubMed ID: 28886943
[TBL] [Abstract][Full Text] [Related]
5. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
Front Immunol; 2021; 12():692700. PubMed ID: 34335603
[TBL] [Abstract][Full Text] [Related]
6. Bivalent Hemagglutinin Cleavage-Site Peptide Vaccines Protect Chickens from Lethal Infections with Highly Pathogenic H5N1 and H5N6 Avian Influenza Viruses.
Chowdhury D; Lin XH; Seo SH
Front Biosci (Landmark Ed); 2024 Feb; 29(2):61. PubMed ID: 38420817
[TBL] [Abstract][Full Text] [Related]
7. Spillover of an endemic avian Influenza H6N2 chicken lineage to ostriches and reassortment with clade 2.3.4.4b H5N1 high pathogenicity viruses in chickens.
Abolnik C
Vet Res Commun; 2024 Apr; 48(2):1233-1237. PubMed ID: 37966679
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
Rudenko L; Desheva J; Korovkin S; Mironov A; Rekstin A; Grigorieva E; Donina S; Gambaryan A; Katlinsky A
Influenza Other Respir Viruses; 2008 Nov; 2(6):203-9. PubMed ID: 19453396
[TBL] [Abstract][Full Text] [Related]
9. Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck.
Rizal FA; Ho KL; Omar AR; Tan WS; Mariatulqabtiah AR; Iqbal M
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895321
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
Kapczynski DR; Chrzastek K; Shanmugasundaram R; Zsak A; Segovia K; Sellers H; Suarez DL
Virol J; 2023 Dec; 20(1):298. PubMed ID: 38102683
[TBL] [Abstract][Full Text] [Related]
11. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Rudenko L; Naykhin A; Donina S; Korenkov D; Petukhova G; Isakova-Sivak I; Losev I; Stukova M; Erofeeva M; Nikiforova A; Power M; Flores J
Hum Vaccin Immunother; 2015; 11(12):2839-48. PubMed ID: 26697973
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens.
Spackman E; Suarez DL; Lee CW; Pantin-Jackwood MJ; Lee SA; Youk S; Ibrahim S
Vaccine; 2023 Nov; 41(49):7369-7376. PubMed ID: 37932132
[TBL] [Abstract][Full Text] [Related]
13. Characterization of four novel H5N6 avian influenza viruses with the internal genes from H5N1 and H9N2 viruses and experimental challenge of chickens vaccinated with current commercially available H5 vaccines.
Peng C; Zhao P; Chu J; Zhu J; Li Q; Zhao H; Li Y; Xin L; Yang X; Xie S; Zhu C; Qi W; Xu G; Li J
Transbound Emerg Dis; 2022 May; 69(3):1438-1448. PubMed ID: 33872465
[TBL] [Abstract][Full Text] [Related]
14. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolates.
Gao Y; Wen Z; Dong K; Zhong G; Wang X; Bu Z; Chen H; Ye L; Yang C
PLoS One; 2012; 7(7):e41332. PubMed ID: 22859976
[TBL] [Abstract][Full Text] [Related]
16. Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.
Youk SS; Leyson CM; Seibert BA; Jadhao S; Perez DR; Suarez DL; Pantin-Jackwood MJ
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268526
[TBL] [Abstract][Full Text] [Related]
17. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.
Legastelois I; Garcia-Sastre A; Palese P; Tumpey TM; Maines TR; Katz JM; Vogel FR; Moste C
Influenza Other Respir Viruses; 2007 May; 1(3):95-104. PubMed ID: 19453414
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions in PB1 of avian influenza viruses influence pathogenicity and transmissibility in chickens.
Suzuki Y; Uchida Y; Tanikawa T; Maeda N; Takemae N; Saito T
J Virol; 2014 Oct; 88(19):11130-9. PubMed ID: 25031333
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage.
Kong D; He Y; Wang J; Chi L; Ao X; Ye H; Qiu W; Zhu X; Liao M; Fan H
Emerg Microbes Infect; 2024 Dec; 13(1):2287682. PubMed ID: 37994795
[TBL] [Abstract][Full Text] [Related]
20. Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
Pushko P; Tretyakova I; Hidajat R; Sun X; Belser JA; Tumpey TM
Vaccine; 2018 Jul; 36(29):4346-4353. PubMed ID: 29885769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
